How Biotechs Are Using Organ Chips to Replace Animal Testing

Episode 39 of Biotech Business with Fexingo dives into organ-on-a-chip technology—tiny devices lined with living human cells that mimic organs like lungs, livers, and hearts. Lucas and Luna explore how startups such as Emulate and TissUse are replacing animal models with these chips to accelerate drug development and cut costs. They break down the science behind the chips, highlight a case where a liver chip predicted a drug's toxicity that animal tests missed, and discuss the regulatory push from the FDA's recent mandate to reduce animal testing. The episode also touches on the market—projected to reach $5.6 billion by 2030—and the challenges of scaling manufacturing. If you're in biotech or curious about how drugs actually get approved, this is a concrete look at a technology reshaping preclinical research. #OrganOnAChip #OrgansOnChips #AnimalTestingAlternatives #DrugDiscovery #PreclinicalResearch #EmulateBio #TissUse #FDA #FDAModernizationAct #BiotechStartups #LifeSciences #Microfluidics #LiverChip #LungChip #HeartChip #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo